A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle

European Cells and Materials

Volumn 22, Issue , 2011, Pages 109-123

  Kuraitis, D ^a,b,c   Zhang, P ^a   Zhang, Y ^a,b   Padavan, D T ^a   McEwan, K ^a,b   Sofrenovic, T ^a,b   McKee, D ^a   Zhang, J ^d   Griffith, M ^b,e   Cao, X ^b   Musaro A ^c   Ruel, M ^a,b   Suuronen, E J ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cytokines; Hydrogels; Injectables; Neovascularisation; Regenerative medicine; Vascular biology

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MICROSPHERE; STROMAL CELL DERIVED FACTOR 1; COLLAGEN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GELATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; MUSCLE ISCHEMIA; NANOENCAPSULATION; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; TISSUE REGENERATION; VISCOSITY; ANIMAL; CHEMOTAXIS; DRUG DELIVERY SYSTEM; HINDLIMB; ISCHEMIA; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; STEM CELL; VASCULARIZATION;

ANIMALS; CHEMOKINE CXCL12; CHEMOTAXIS; COLLAGEN; DRUG DELIVERY SYSTEMS; HINDLIMB; ISCHEMIA; MICE; MICROSPHERES; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 84855163314     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v022a09     Document Type: Article

References (57)

1. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703.
2. Balciunas M, Bagdonaite L, Samalavicius R, Baublys A (2009) Markers of endothelial dysfunction after cardiac surgery: soluble forms of vascular-1 and intercellular-1 adhesion molecules. Medicina (Kaunas) 45: 434-439.
3. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA; Prevention of Atherothrombotic Disease Network (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163: 884-892.
4. th ed. Marcel Dekker Inc., New York, pp 67-92.
5. Cadee JA, de Groot CJ, Jiskoot W, den Otter W, Hennink WE (2002) Release of recombinant human interleukin-2 from dextran-based hydrogels. J Control Release 78: 1-13.
6. Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, Jeong JO, Curry C, Qin G, Yoon YS (2007) Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischaemic heart. J Exp Med 204: 3257-3269.
7. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M (2004) SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482.
8. Deng C, Zhang P, Vulesevic B, Kuraitis D, Li F, Yang AF, Griffith M, Ruel M, Suuronen EJ (2010) A collagen-chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng Part A 16: 3099-3109.
9. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, Verma S, Weisel RD, Keating A, Li RK (2006) Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116: 1865-1877.
10. Formigli L, Perna AM, Meacci E, Cinci L, Margheri M, Nistri S, Tani A, Silvertown J, Orlandini G, Porciani C, Zecchi-Orlandini S, Medin J, Bani D (2007) Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling. J Cell Mol Med 11: 1087-1100.
11. Hadjiioannou TP, Christian GD, Koupparis MA, Macheras PE (1993) Quantitative Calculations in Pharmaceutical Practice and Research. VCH Publishers Inc., New York, pp 345-348.
12. Higuchi T (1963) Mechanism of Sustained-Action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices. J Pharm Sci 52: 1145-1149.
13. Hixson AW, Crowell JH (1931) Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind Eng Chem 23: 923-931.
14. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, Ganser A, Knapp WH, Drexler H (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202.
15. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H, Tabata Y (2006) Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials 27: 5836-5844.
16. Kaully T, Kaufman-Francis K, Lesman A, Levenberg S (2009) Vascularisation - the conduit to viable engineered tissues. Tissue Eng Part B Rev 15: 159-169.
17. Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, Dhert WJ, Yaszemski MJ (2008) Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 29: 3245-3252.
18. Kim HK, De La Luz Sierra M, Williams CK, Gulino AV, Tosato G (2006) G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 108: 812-820.
19. Kim SW, Kim H, Cho HJ, Lee JU, Levit R, Yoon YS (2010) Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol 56: 593-607.
20. Kimura Y, Tabata Y (2010) Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 21: 37-51.
21. Ko HC, Milthorpe BK, McFarland CD (2007) Engineering thick tissues - the vascularisation problem. Eur Cells Mater 14: 1-18.
22. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15: 25-35.
23. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P (1997) Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100: 1991-1999.
24. Limbourg A, Korff T, Napp LC, Schaper W, Drexler H, Limbourg FP (2009) Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc 4: 1737-1746.
25. Liu W, Griffith M, Li F (2008) Alginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation. J Mater Sci 19: 3365-3371.
26. Misiak-Tloczek A, Brzezinska-Blaszczyk E (2009) IL-6, but not IL-4, stimulates chemokinesis and TNF stimulates chemotaxis of tissue mast cells: involvement of both mitogen-activated protein kinases and phosphatidylinositol 3-kinase signalling pathways. APMIS 117: 558-567.
27. Mitra T, Sailakshmi G, Gnanamani A, Raja ST, Thiruselvi T, Gowri VM, Selvaraj NV, Ramesh G, Mandal AB (2011) Preparation and characterization of a thermostable and biodegradable biopolymers using natural cross-linker. Intl J Biol Macromol 48: 276-285.
28. Murry CE, Reinecke H, Pabon LM (2006) Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 47: 1777-1785.
29. Park S, Tepper OM, Galiano RD, Capla JM, Baharestani S, Kleinman ME, Pelo CR, Levine JP, Gurtner GC (2004) Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization. Plast Reconstr Surg 113: 284-293.
30. Pelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, Nicoletti C, Wannenes F, Battistini L, Rosenthal N, Molinaro M, Musarò A (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J 21: 1393-1402.
31. Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R, Penn M (2010) Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant 19: 399-408.
32. Ruel M, Suuronen EJ, Song J, Kapila V, Gunning D, Waghray G, Rubens FD, Mesana TG (2005) Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. J Thorac Cardiovasc Surg 130: 633-639.
33. Ruvinov E, Leor J, Cohen S (2010) The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials 31: 4573-4582.
34. Ruvinov E, Leor J, Cohen S (2011) The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32: 565-578.
35. Sandstedt J, Jonsson M, Lindahl A, Jeppsson A, Asp J (2010) C-kit+ CD45-cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Res Cardiol 105: 545-556.
36. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S (2009) CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscl Thromb Vasc Biol 29: 1802-1809.
37. Selvin E, Erlinger TP (2004) Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110: 738-743.
38. Shamoun F, Sural N, Abela G (2008) Peripheral artery disease: therapeutic advances. Expert Rev Cardiovasc Ther 6: 539-553.
39. Su EJ, Cioffi CL, Stefansson S, Mittereder N, Garay M, Hreniuk D, Liau G (2003) Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization. Am J Physiol Heart Circ Physiol 284: H1429-1440.
40. Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo XW, Wong S, Mesana TG, Ruel M (2007) Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J Thorac Cardiovasc Surg 134: 1249-1258.
41. Suuronen EJ, Zhang P, Kuraitis D, Cao X, Melhuish A, McKee D, Li F, Mesana TG, Veinot JP, Ruel M (2009) An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 23: 1447-1458.
42. Suuronen EJ, Hazra S, Zhang P, Vincent R, Kumarathasan P, Zhang Y, Price J, Chan V, Sellke FW, Mesana TG, Veinot JP, Ruel M (2010) Impairment of human cell-based vasculogenesis in rats by hypercholesterolemia-induced endothelial dysfunction and rescue with L-arginine supplementation. J Thorac Cardiovasc Surg 139: 209-216. e2.
43. Takagi Y, Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Hashimoto I, Hayashi Y, Kawabe T, Shimokata K, Hasegawa Y (2009) Erythromycin-induced CXCR4 expression on microvascular endothelial cells. Am J Physiol 297: L420-431.
44. Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, Tang L (2010) The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 31: 3997-4008.
45. Turan RG, Bozdag-Turan I, Ortak J, Akin I, Kische S, Schneider H, Turan CH, Rehders TC, Rauchhaus M, Kleinfeldt T, Adolph E, Brehm M, Yokus S, Steiner S, Sahin K, Nienaber CA, Ince H (2010) Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease. Stem Cells Dev, in press.
46. Whitman SC, Rateri DL, Szilvassy SJ, Yokoyama W, Daugherty A (2004) Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscl Thromb Vasc Biol 24: 1049-1054.
47. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochała A, Ratajczak MZ (2004) Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110: 3213-3220.
48. Yang J, Wang F, Tianwei T (2010) Degradation behavior of hydrogel based on crosslinked poly(aspartic acid). J Appl Polym Sci 117: 178-185.
49. Zhang G, Nakamura Y, Wang X, Hu Q, Suggs LJ, Zhang J (2007) Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 13: 2063-2071.
50. Fassbender M, Strobel C, Rauhe JS, Bergmann C, Schmidmaier G, Wildemann B (2011) Local inhibition of angiogenesis results in an atrophic non-union in a rat osteotomy model. Eur Cells Mater 22: 1-11.
51. Fujio M, Yamamoto A, Ando Y, Shohara R, Kinoshita K, Kaneko T, Hibi H, Ueda M (2011) Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors. Bone, in press.
52. Giannoudis PV, Einhorn TA, Schmidmaier G, Marsh D (2008) The diamond concept - open questions. Injury 39: 5-8.
53. Ho TK, Tsui J, Xu S, Leoni P, Abraham DJ, Baker DM (2010) Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia. J Vasc Surg 51: 689-699.
54. Reddy K, Zhou Z, Jia SF, Lee TH, Morales-Arias J, Cao Y, Kleinerman ES (2008) Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer 15: 831-837.
55. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT (2007) Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116: 1683-1692.
56. Sundararaman S, Miller TJ, Pastore JM, Kiedrowski M, Aras R, Penn MS (2011) Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Ther, in press.
57. Van Weel V, Toes RE, Seghers L, Deckers MM, de Vries MR, Eilers PH, Sipkens J, Schepers A, Eefting D, van Hinsbergh VW, van Bockel JH, Quax PH (2007) Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol 27: 2050-2057.